We then performed immunohistochemical analysis in tumor sections that showed a higher proportion of CXCL9-dependent infiltrating CD3+ and CD8+ TILs (Chow et al, 2019; Dangaj et al, 2019; Marcovecchio et al, 2021) in Pant samples (Fig 5G and H), whereas they were in reduced numbers or confined to the periphery in control tumors. The gene discussed is CXCL9; the disease is neoplasm.